There had been talk in Congress of passing legislation that limits the ability of insurers to have very high percentage co-pays, instead of a flat rate such as $10 or $20 or even $100 per month. I think it did not go anywhere last year, and certainly is unlikely to be brought up again in an election year.
However, in the long run legislation is the best way to go, as insurers are likely to use this tactic of high co-pays more and more in the future. Already nearly 20% of employers have these plans, and more and more patients will be shut off from necessary treatment if out-of-pocket costs are going to be thousands of dollars per year.
Meanwhile those of us with these high co-pays are just out of luck unless we happen to be very wealthy. I am not, so I had to quit taking Copaxone, but I had pretty much decided it wasn't worth it to me anyway, being older and with few relapses. But what about someone new to RRMS with frequent relapses who has a real chance of lessening progression with a DMD?
However, in the long run legislation is the best way to go, as insurers are likely to use this tactic of high co-pays more and more in the future. Already nearly 20% of employers have these plans, and more and more patients will be shut off from necessary treatment if out-of-pocket costs are going to be thousands of dollars per year.
Meanwhile those of us with these high co-pays are just out of luck unless we happen to be very wealthy. I am not, so I had to quit taking Copaxone, but I had pretty much decided it wasn't worth it to me anyway, being older and with few relapses. But what about someone new to RRMS with frequent relapses who has a real chance of lessening progression with a DMD?
Comment